Smithfield Trust CO Atara Biotherapeutics, Inc. Transaction History

Smithfield Trust CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	BUY	$14.0 - $20.72 $2,520 - $3,729	180 Added 33.15%	723 $10,000
Q4 2020 Feb 12, 2021	BUY	$12.67 - $26.23 $2,293 - $4,747	181 Added 50.0%	543 $11,000
Q2 2020 Aug 14, 2020	BUY	$7.53 - $14.93 $1,362 - $2,702	181 Added 100.0%	362 $5,000
Q4 2018 Feb 04, 2019	BUY	$30.9 - $42.97 $5,592 - $7,777	181 New	181 $6,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.13B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Smithfield Trust CO, based on Form 13F filings with the SEC.

Stay updated on Smithfield Trust CO with notifications on news.